PYRIMIDOPYRIDAZINE DERIVATIVES USEFUL AS P38 MAPK INHIBITORS
申请人:Beswick Amanda
公开号:US20120077809A1
公开(公告)日:2012-03-29
A compound formula (IA) or (IB), or a pharmaceutically acceptable thereof; wherein the substituents are defined as in the claims, and their use as P38 MAP kinase.
Pyrimidopyridazine derivatives useful as P38 MAPK inhibitors
申请人:Beswick Amanda
公开号:US08450314B2
公开(公告)日:2013-05-28
A compound formula (IA) or (IB), or a pharmaceutically acceptable thereof; wherein the substituents are defined as in the claims, and their use as P38 MAP kinase.
[EN] PYRIMIDOPYRIDAZINE DERIVATIVES USEFUL AS P38 MAPK INHIBITORS<br/>[FR] DÉRIVÉS DE PYRIMIDOPYRIDAZINE UTILES COMME INHIBITEURS DE LA P38 MAP KINASE
申请人:PULMAGEN THERAPEUTICS INFLAMMA
公开号:WO2010094955A1
公开(公告)日:2010-08-26
A compound formula (IA) or (IB), or a pharmaceutically acceptable thereof; wherein the substituents are defined as in the claims, and their use as P38 MAP kinase.